Recent advances in genomic sequencing, multi-omics profiling, and AI-driven analysis are redefining personalized medicine, enabling earlier disease detection, targeted therapies, and more inclusive ...

Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to advance cancer therapy ...

A new strategy to strengthen the body’s natural immune defenses against cancer is showing early promise, particularly for patients with limited treatment options.

Researchers from Inocras, a bioinformatics-led company harnessing the power of whole-genome data and proprietary analytics to ...

Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among the large number of variants of uncertain significance (VUS) detected in ...

For patients with challenging cancers like lymphoma and sarcoma, subtle genetic differences can dramatically change the way doctors diagnose and treat their disease. There are more than 70 recognized ...

Cancer treatment is undergoing a quiet revolution. Increasingly, what matters most is not where a tumour begins, but what is ...

For decades, oncologists have had a powerful but imperfect ally in the fight against cancer: genomic testing. The ability to ...

The MarketWatch News Department was not involved in the creation of this content. Singular Genomics and Vanderbilt University Medical Center Establish Center of Excellence to Advance High-Throughput ...

Researchers have developed a powerful new tool that can track how microbes spread between people with unprecedented precision ...